论文部分内容阅读
对40 例合并门静脉癌栓(PTT) 的原发性肝癌(PHC) 行多次化学栓塞治疗。结果治疗总有效率为67-5 % ,治疗后0-5 ,1 及3 年生存率分别为75-0 % ,12-5 % 及2-5 % ,平均生存期9 月。合并分支PTT 者治疗有效率高于合并其他部位PTT者( P < 0 .05) 。平均治疗间隔期的长短对疗效的影响差异无显著性( P > 0 .05) 。提示在掌握适应症的前提下,TAI+ TAE 是合并PTT 的PHC 的有效治疗方法;不论PTT 分布在何部位,均应积极处理;治疗间隔期应视病人情况而定
A total of 40 cases of primary liver cancer (PHC) with portal vein tumor embolus (PTT) were treated with multiple chemoembolization. Results The total effective rate of treatment was 67-5 %. The 0-5, 1 and 3 year survival rates after treatment were 75-0 %, 12-5 % and 2-5 %, respectively. The average survival time was 9 months. The combined PTT patients were more effective than those with other PTT (P < 0.05). The effect of the average treatment interval on the curative effect was not significant (P > 0.05). Tip: Under the premise of mastering indications, TAI+TAE is an effective treatment method for PHC with PTT; regardless of the location of PTT, it should be actively treated; treatment interval should be determined according to the patient’s condition.